A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis

BACKGROUND: This study evaluated two doses of etoricoxib (60 and 90 mg) vs. naproxen 1000 mg in subjects with ankylosing spondylitis (AS). METHODS: This was a 2-part, double-blind, active comparator-controlled non-inferiority study in subjects ≥18 years of age with AS. In Part I, subjects were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Balazcs, Eva, Sieper, Joachim, Bickham, Kara, Mehta, Anish, Frontera, Nancy, Stryszak, Paul, Popmihajlov, Zoran, Peloso, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062857/
https://www.ncbi.nlm.nih.gov/pubmed/27737664
http://dx.doi.org/10.1186/s12891-016-1275-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062857/
https://www.ncbi.nlm.nih.gov/pubmed/27737664
http://dx.doi.org/10.1186/s12891-016-1275-5

Ejemplares similares